TRTN-PE(TRTN-PE)
TRTN-PE
Q4 2026 EPS Estimate
$1.97
Nov 3, 2026
Revenue Estimate
$376M
Analyst Sentiment
Wall St. Consensus
Hold5 analysts·Limited coverage
50
Score
1 Buy (20%)3 Hold (60%)1 Sell (20%)
Rating Breakdown
Strong Buy
00%
Buy
120%
Hold
360%
Sell
120%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for TRTN-PE
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Raw consensus estimates (low / average / high) from covering analysts.
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $376M | $404M | $429M | $426M | $427M | $428M | $425M | $409M |
| Low | $376M | $404M | $429M | $426M | $427M | $428M | $425M | $409M |
| High | $376M | $404M | $429M | $426M | $427M | $428M | $425M | $409M |
| EBITDA Avg | $315M | $339M | $360M | $357M | $358M | $359M | $357M | $343M |
| Low | $315M | $339M | $360M | $357M | $358M | $359M | $357M | $343M |
| High | $315M | $339M | $360M | $357M | $358M | $359M | $357M | $343M |
| EBIT Avg | $187M | $201M | $214M | $212M | $212M | $213M | $212M | $204M |
| Low | $187M | $201M | $214M | $212M | $212M | $213M | $212M | $204M |
| High | $187M | $201M | $214M | $212M | $212M | $213M | $212M | $204M |
| Net Income Avg | $199M | $221M | $255M | $267M | $268M | $280M | $273M | $232M |
| Low | $199M | $221M | $255M | $267M | $268M | $280M | $273M | $232M |
| High | $199M | $221M | $255M | $267M | $268M | $280M | $273M | $232M |
| EPS Avg | $1.97 | $2.19 | $2.52 | $2.63 | $2.65 | $2.77 | $2.70 | $2.30 |
| Low | $1.97 | $2.19 | $2.52 | $2.63 | $2.65 | $2.77 | $2.70 | $2.30 |
| High | $1.97 | $2.19 | $2.52 | $2.63 | $2.65 | $2.77 | $2.70 | $2.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions